SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-042477
Filing Date
2013-05-16
Accepted
2013-05-16 17:11:30
Documents
10
Period of Report
2013-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-12556_28k.htm 8-K 34953
2 EX-1.1 a13-12556_2ex1d1.htm EX-1.1 207803
3 EX-5.1 a13-12556_2ex5d1.htm EX-5.1 13891
4 EX-99.1 a13-12556_2ex99d1.htm EX-99.1 13117
5 EX-99.2 a13-12556_2ex99d2.htm EX-99.2 13472
6 GRAPHIC g125562mmi001.jpg GRAPHIC 3409
7 GRAPHIC g125562mmi002.jpg GRAPHIC 2014
8 GRAPHIC g125562moi001.jpg GRAPHIC 3409
9 GRAPHIC g125562moi002.jpg GRAPHIC 2014
10 GRAPHIC g125562kei001.jpg GRAPHIC 2636
  Complete submission text file 0001104659-13-042477.txt   303843
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 13852259
SIC: 2834 Pharmaceutical Preparations